Reductions in brain phosphatidylinositol kinase activities in Alzheimer's disease

Biological Psychiatry

Volumn 45, Issue 6, 1999, Pages 731-736

  Zubenko, George S ^a,b   Stiffler, J Scott ^a   Hughes, Hugh B ^a   Martinez, A Julio ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Phosphatidylinositol kinase; Protein sorting and trafficking

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL KINASE;

AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN TARGETING; PROTEIN TRANSPORT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 1-PHOSPHATIDYLINOSITOL 4-KINASE; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; CULTURE TECHNIQUES; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 0033558966     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00073-0     Document Type: Article

References (54)

1. Backer J.M., Myers M.G., Shoelson S.E., Chin D.J., Sun X.J., Miralpeix M., et al. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11:1992;3469-3479.
2. Brown W.J., DeWald D.B., Emr S.D., Plutner H., Balch W.E. Role for phosphatidylinositol 3-kinase in the sorting and transport of newly synthesized lysosomal enzymes in mammalian cells. J Cell Biol. 130:1995;781-796.
3. Carpenter C.L., Duckworth B.C., Auge K.R., Cohen B., Schaffhausen B.S., Cantley L.C. Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem. 265:1990;19704-19711.
4. Cataldo A.M., Barnett J.L., Pieroni C., Nixon R.A. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease Neuropathologic evidence for a mechanism of increased β-amyloidogenesis . J Neurosci. 17:1997;6142-6151.
5. Chakravarti A., Slaugenhaupt S., Zubenko G.S. Inheritance pattern of platelet membrane fluidity in Alzheimer's disease. Am J Hum Genet. 44:1989;799-805.
6. Chang H.W., Aoki M., Fruman D., Auger K.R., Bellacosa A., Tsichlis P.N., et al. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science. 276:1997;1848-1850.
7. Cheatham B., Vlahos C.J., Cheathan L., Wang L., Blenis J., Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol. 14:1994;4902-4911.
8. Cohen B.M., Zubenko G.S., Babb S. Abnormal platelet membrane composition in Alzheimer's disease. Life Sci. 40:1987;2445-2451.
9. Del Vecchio R.L., Pilch P.F. Phosphatidylinositol 4-kinase is a component of glucose transporter (GLUT 4)-containing vesicles. J Biol Chem. 266:1991;13278-13283.
10. GDB(TM) (1990-): Human Genome Database (database on-line). Baltimore, MD: Johns Hopkins University. Updated daily. Available from Internet: URL http://www.gdb.org/ (cited November 17, 1997; GDB node: USA, http://www.gdb.org/); GDB data type: Gene; object name: PIK3R2; accession ID: GDB: 132614.
11. Glenner G.G., Wong C.W. Alzheimer's disease Initial report of the purification and characterization of a novel cerebrovascular amyloid protein . Biochem Biophys Res Commun. 120:1984;885-890.
12. Gottlieb S., Runkun G. Daf-2, daf-16 and daf-23 Genetically interacting genes controlling Dauer formation in Caenorhabditis elegans . Genetics. 137:1994;107-120.
13. Hajimohammadreza I., Brammer M.J., Eagger S., Burns A., Levy R. Platelet and erythrocyte membrane changes in Alzheimer's disease. Biochim Biophys Acta. 1025:1990;208-214.
14. Hara K., Yonezawa K., Sakau H., Ando A., Kotani K., Kitamura T., et al. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci USA. 91:1994;7415-7419.
15. Hartmann T., Bieger S.C., Bruhl B., Tienari P.J., Ida N., Allsop D. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nat Med. 9:1997;1016-1020.
16. Hiles I.D., Otsu M., Volinia S., Fry M.J., Gout I., Dhand R., et al. Phosphatidylinositol 3-kinase Structure and expression of the 110 kd catalytic subunit . Cell. 70:1992;419-429.
17. Kapeller R., Chakrabarti R., Cantley L., Fay F., Corvera S. Internalization of activated platelet-derived growth factor receptor-phosphatidylinositol-3′ kinase complexes Potential interactions with the microtubule cytoskeleton . Mol Cell Biol. 13:1993;6052-6063.
18. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch Neurol. 42:1985;1097-1105.
19. Koch C.A., Anderson D., Moran M.F., Ellis C., Pawson T. SH2 and SH3 domains Elements that control interactions of cytoplasmic signaling proteins . Science. 252:1991;668-674.
20. Kotani K., Yonezawa K., Hara K., Ueda H., Kitamura Y., Sakaue H., et al. Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling. EMBO J. 13:1994;2313-2321.
21. Kovacs D.M., Fausett H.J., Page K.J., Kim T.-W., Moir R.D., Merriam D.E., et al. Alzheimer-associated presenilins 1 and 2 Neuronal expression in brain and localization to intracellular membranes in mammalian cells . Nat Med. 2:1996;224-229.
22. Leevers S.J., Weinkove D., MacDougall L.K., Hafen E., Waterfield M.D. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15:1996;6584-6594.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-276.
24. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 82:1985;4245-4249.
25. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Neurology. 41:1991;479-486.
26. Moossy J., Zubenko G.S., Martinez A.J., Rao G.R. Bilateral symmetry of morphologic lesions in Alzheimer's disease. Arch Neurol. 45:1988;251-254.
27. Morris J.Z., Tissenbaum H.A., Ruvjun G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature. 382:1996;536-539.
28. Nobes C.D., Hawkins P., Stephens L., Hall A. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J Cell Sci. 108:1995;225-233.
29. Ohmichi M., Decker S.J., Saltiel A.R. Activation of phosphatidylinositol-3 kinase by nerve growth factor involves indirect coupling of the trk proto-oncogene with src homology 2 domains. Neuron. 9:1992;769-977.
30. Okada T., Kawano Y., Sakakibara T., Hazeki O., Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem. 269:1994;3568-3573.
31. Otsu M., Hiles I., Gout I., Fry M.J., Ruiz-Larrea F., Panayotou G., et al. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell. 65:1991;91-104.
32. Pericak-Vance M.A., Haines J.L. Genetic susceptibility to Alzheimer's disease. Trends Genet. 11:1995;504-508.
33. Piletz J.E., Sarasua M., Whitehouse P., Chotani M. Intracellular membranes are more fluid in platelets of Alzheimer's disease patients. Neurobiol Aging. 12:1991;401-406.
34. Schellenberg G.D. Progress in Alzheimer's disease genetics. Curr Opin Neurol. 8:1995;262-267.
35. Schu P.V., Takegawa K., Fry M.J., Stack J.H., Waterfield M.D., Emr S.D. Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science. 260:1993;88-91.
36. Selkoe D.J. Amyloid β-protein and the genetics of Alzheimer's disease. J Biol Chem. 271:1996;18295-18298.
37. Shibasaki F., Homma Y., Takenawa T. Two types of phosphatidylinositol 3-kinase from bovine thymus. Monomer and heterodimer form. J Biol Chem. 266:1991;8108-8114.
38. Soltoff S.P., Rabin S.L., Cantley L.C., Kaplan D.R. Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase. J Biol Chem. 267:1992;17472-17477.
39. Stack J.H., Herman P.K., Schu P.V., Emr S.D. A membrane-associated complex containing the Vps15 protein kinase and the Vps34 PI 3-kinase is essential for protein sorting to the yeast lysosome-like vacuole. EMBO J. 12:1993;2195-2204.
40. Tienari P.J., Ida N., Ikonen E., Simons M., Weidemann A., Multhaup G. Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc Natl Acad Sci USA. 94:1997;4125-4130.
41. Volinia S., Patracchini P., Otsu M., Hiles I., Gout I., et al. Chromosomal localization of human p85 alpha, a subunit of phosphatidylinositol 3-kinase, and its homologue p85 beta. Oncogene. 7:1992;789-793.
42. Walsh J.P., Caldwell K.K., Majerus P.W. Formation of phosphatidylinositol 3-phosphate by isomerization from phosphatidylinositol 4-phosphate. Proc Natl Acad Sci USA. 88:1991;9184-9187.
43. Whitman M., Downes C.P., Keeler M., Keller T., Cantley L. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature. 332:1988;644-646.
44. Xu H., Sweeney D., Wang R., Thinakaran G., Lo A.C.Y., Sisodia S.S., et al. Generation of Alzheimer β-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci USA. 94:1997;3748-3752.
45. Yan S.D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F., et al. An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease. Nature. 389:1997;689-695.
46. Yao R., Cooper G.M. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 267:1995;2003-2006.
47. Zubenko G.S. Endoplasmic reticulum abnormality in Alzheimer's disease Selective alteration in platelet NADH-cytochrome C reductase activity . J Geriatr Psychiatry Neurol. 2:1989;3-10.
48. Zubenko G.S. Biological correlates of clinical heterogeneity in primary dementia. Neuropsychopharmacology. 6:1992;77-93.
49. Zubenko G.S. Molecular neurobiology of Alzheimer's disease (syndrome?). Harvard Rev Psychiatry. 5:1997;1-37.
50. Zubenko G.S., Ferrell R.E. Monozygotic twins concordant for probable Alzheimer's disease and abnormal platelet membrane fluidity. Am J Med Genet. 29:1988;431-436.
51. Zubenko G.S., Malinakova I., Chojnacki B. Proliferation of internal membranes in platelets from patients with Alzheimer's disease. J Neuropathol Exp Neurol. 46:1987;407-418.
52. Zubenko G.S., Wusylko M., Boller F., Cohen B.M., Teply I. Family study of platelet membrane fluidity in Alzheimer's disease. Science. 238:1987;539-542.
53. Zubenko G.S., Huff F.J., Beyer J., Auerbach J., Teply I. Familial risk of dementia associated with a biologic subtype of Alzheimer's disease. Arch Gen Psychiatry. 45:1988;889-893.
54. Zubenko G.S., Teply I., Winwood E., Huff F.J., Moossy J., Sunderland T., et al. Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease Results at five years . Am J Psychiatry. 153:1996;420-423.